You are here

Publications

Found 708 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is M  [Clear All Filters]
2000
Ma X, Sun J, Papasavvas E, Riemann H, Robertson S, Marshall J, Bailer RT, Moore A, Donnelly RP, Trinchieri G et al..  2000.  Inhibition of IL-12 production in human monocyte-derived macrophages by TNF.. J Immunol. 164(4):1722-9.
Ma X, Sun J, Papasavvas E, Riemann H, Robertson S, Marshall J, Bailer RT, Moore A, Donnelly RP, Trinchieri G et al..  2000.  Inhibition of IL-12 production in human monocyte-derived macrophages by TNF.. J Immunol. 164(4):1722-9.
Ma X, Montaner LJ.  2000.  Proinflammatory response and IL-12 expression in HIV-1 infection.. J Leukoc Biol. 68(3):383-90.
Ma X, Montaner LJ.  2000.  Proinflammatory response and IL-12 expression in HIV-1 infection.. J Leukoc Biol. 68(3):383-90.
Schwer B, Meszaros T.  2000.  RNA helicase dynamics in pre-mRNA splicing.. EMBO J. 19(23):6582-91.
1999
Pardoux C, Ma X, Gobert S, Pellegrini S, Mayeux P, Gay F, Trinchieri G, Chouaib S.  1999.  Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling.. Blood. 93(5):1448-55.
Pardoux C, Ma X, Gobert S, Pellegrini S, Mayeux P, Gay F, Trinchieri G, Chouaib S.  1999.  Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling.. Blood. 93(5):1448-55.
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG.  1999.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.
Peng Y, Trevejo J, Zhou J, Marino MW, Crystal RG, Falck-Pedersen E, Elkon KB.  1999.  Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.. J Virol. 73(6):5098-109.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS.  1999.  Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.. J Biol Chem. 274(12):7674-80.
Cole-Strauss A, Gamper H, Holloman WK, Muñoz M, Cheng N, Kmiec EB.  1999.  Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract.. Nucleic Acids Res. 27(5):1323-30.
1998
Aste-Amezaga M, Ma X, Sartori A, Trinchieri G.  1998.  Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.. J Immunol. 160(12):5936-44.
Ma X, Riemann H, Gri G, Trinchieri G.  1998.  Positive and negative regulation of interleukin-12 gene expression.. Eur Cytokine Netw. 9(3 Suppl):54-64.
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.  1998.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.  1998.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.
Gri G, Savio D, Trinchieri G, Ma X.  1998.  Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages.. J Biol Chem. 273(11):6431-8.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
1997
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Ma X, Neurath M, Gri G, Trinchieri G.  1997.  Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter.. J Biol Chem. 272(16):10389-95.
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan C.  1997.  Identification of nitric oxide synthase as a protective locus against tuberculosis.. Proc Natl Acad Sci U S A. 94(10):5243-8.
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan C.  1997.  Identification of nitric oxide synthase as a protective locus against tuberculosis.. Proc Natl Acad Sci U S A. 94(10):5243-8.